NASDAQ · TLSI
TriSalus Life Sciences, Inc.
$3.86-$0.07 (-1.78%)
TriSalus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.45% below the high.
Loading market information…
NASDAQ · QDRO · USD
Stock price, earnings
Quote as of May 28, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Quadro Acquisition One Corp.’s quoted price sits in the lower half of its reported 52-week range, 6.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Quadro Acquisition One Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Quadro Acquisition One Corp. currently lacks active operations. Its primary objective is to execute an initial business combination, which could involve an acquisition, merger, asset purchase, or other form of control arrangement, with one or more target businesses or operating entities. The company, previously known as Kismet Acquisition Two Corp., officially rebranded as Quadro Acquisition One Corp. in February 2023. Established in 2020, its principal office is located in Newark, Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$3.86-$0.07 (-1.78%)
TriSalus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.45% below the high.
$11.00-$0.01 (-0.09%)
Noble Rock Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 8.18% below the high.
$10.25+$0.01 (+0.05%)
Belong Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 4.12% below the high.
$11.74-$0.02 (-0.17%)
Valuence Merger Corp. I’s quoted price sits in the upper half of its reported 52-week range, 0.42% below the high.
$11.00+$0.02 (+0.18%)
AI Transportation Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.18% below the high.
$10.12-$0.13 (-1.27%)
Altitude Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 3.16% below the high.
$10.76$0.00 (0.0%)
Portage Fintech Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 16.98% below the high.
$10.65+$0.01 (+0.09%)
Edify Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 6.58% below the high.
